Compas™ represents a significant advance in the fitting and ongoing management of prosthetic device users. This new technology assists practitioners in achieving optimal alignment through objective feedback and analysis using embedded sensor technology. Compas™ marks a significant departure from traditional use of visual observation to align prosthetic devices, an approach that has been established through research as being highly subjective.

R&D 100 Awards salute the 100 most technologically significant products introduced into the marketplace over the past year. Products are chosen by an independent judging panel and the editors of R&D Magazine. 2009 award recipients include Ford, Dow Chemical, Hitachi, Battelle and NASA. A full list of this year's winners is available at www.rdmag.com.

'The R&D 100 Awards honor the latest technology developments that are designed to meet societal, scientific, or business challenges facing us today--and tomorrow,' said Rita Peters, editorial director of R&D Magazine.

'It is an honor to have been chosen as a recipient of the R&D 100 Award, the most respected and highly coveted in the high-tech industry,' added Orthocare Innovations CEO Doug McCormack. 'Though we are an early-stage company, this recognition is testament to our world-class development team, led by Dr. David Boone, Orthocare Innovations' Chief Technology Officer. Compas™ was developed to address a long overlooked, but very real clinical challenge facing users of prosthetic devices. By improving prosthesis alignment, we are confident that we can significantly enhance clinical outcomes for patients worldwide.'

Compas™ was developed with the support of the National Center for Medical Rehabilitation Research, National Institutes of Health, Grant Numbers R43HD047119 and R44HD047119.